🇺🇸 FDA
Patent

US 7108981

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

granted A61KA61K2039/505A61P

Quick answer

US patent 7108981 (Specific binding agents for KSHV vIL-6 that neutralize a biological activity) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61P, A61P31/20, A61P35/00